On Tuesday, Shares of Trevena, Inc. (NASDAQ:TRVN), skyrocketed 51.50% to $9.09, hitting its highest level. Trevena declared positive data from its randomized, double-blind, placebo- and active-controlled Phase 2b ...
Read more
0
NYSE:RIG Best Buy Co.